Skip to content

A clinical study of a new model of regional cooperative treatment and nursing for acute ischemic stroke

A clinical study of a new model of regional cooperative treatment and nursing for acute ischemic stroke

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100042468
Enrollment
Unknown
Registered
2021-01-22
Start date
2020-02-01
Completion date
Unknown
Last updated
2021-04-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute ischemic stroke

Interventions

Intervention group:On the basis of the control group, the Shenzhen AIS intravenous thrombolysis regional collaborative care model was implemented.
Control group:According to the construction standards of the "Guidelines for the Construction of Stroke Centers in China", each designated hospital for stroke treatment has established a stroke green

Sponsors

Shenzhen Second People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: (1) Patients aged >= 18 years; (2) AIS patients who meet the diagnostic criteria of the 2018 China Acute Ischemic Stroke Diagnosis and Treatment Guidelines and are diagnosed by head CT and or MRI; (3) Seeing AIS patients within 4.5 hours of onset; (4) AIS patients receiving rt-PA intravenous thrombolysis.

Exclusion criteria

Exclusion criteria: (1) Patients with incomplete main clinical data (such as incomplete recording of the time of AIS intravenous thrombolysis); (2) Patients with transient ischemic attack (TIA) given intravenous thrombolysis; (3) Patients with AIS in the hospital and undergoing intravenous thrombolytic therapy; (4) Patients with AIS intravenous thrombolysis who refused to participate in this study.

Design outcomes

Primary

MeasureTime frame
Time consuming for each link of the process including the time from consultation to CT examination (DIT), from consultation to CT report (T1), from CT report to intravenous thrombolysis (INT), and from consultation to intravenous thrombolysis (DNT);

Secondary

MeasureTime frame
NIHSS score (before treatment, 24h after treatment, one week after treatment), mRs score, incidence of symptomatic bleeding;

Countries

China

Contacts

Public ContactXiaohua Xie

Shenzhen Second People's Hospital

13560779836@163.com+86 13560779836

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026